![Ian Scott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historial de carrera de Ian Scott
Antiguos cargos conocidos de Ian Scott.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Director/Miembro de la Junta | 01/01/1992 | 01/01/1999 |
ALBANY MOLECULAR RESEARCH, INC. | Director/Miembro de la Junta | - | - |
ACUCELA INC | Corporate Officer/Principal | - | - |
Formación de Ian Scott.
The University of Sheffield | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Reino Unido | 2 |
Operativa
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Acucela, Inc.
![]() Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
Curia Global, Inc.
![]() Curia Global, Inc. BiotechnologyHealth Technology Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Health Technology |
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Ian Scott
- Experiencia